Table 3 Multinomial logistic regression of factors associated with treatment outcomes in HIV-positive TB patients
| Â | Defaulted vs. Successa | Died vs. Successa | Defaulted vs. Successa | Died vs. Successa |
|---|---|---|---|---|
| Â | Unadjusted OR (95Â % CI) | Unadjusted OR (95Â % CI) | Adjusted OR (95Â % CI) | Adjusted OR (95Â % CI) |
Age, years | 1.00 (0.97–1.03) | 1.04* (1.01–1.09) | 1.00 (0.96–1.03) | 1.05* (1.01–1.10) |
Gender | ||||
Male | Ref. | Ref. | Ref. | Ref. |
Female | 0.74 (0.41–1.34) | 1.08 (0.48–2.41) | 0.75 (0.40–1.40) | 1.65 (0.66–4.11) |
Type of TB | ||||
EPTB | Ref. | Ref. | Ref. | Ref. |
Smear-negative PTB | 1.21 (0.59–2.45) | 1.13 (0.44–2.87) | 1.05 (0.51–2.18) | 0.74 (0.26–2.07) |
Smear-positive PTB | 0.97 (0.46–2.05) | 0.92 (0.34–2.47) | 0.85 (0.40–1.82) | 0.68 (0.23–2.01) |
CD4 count, cells/μL | ||||
<50 | Ref. | Ref. | Ref. | Ref. |
50–199 | 0.73 (0.32–1.67) | 0.43 (0.16–1.11) | 0.79 (0.34–1.85) | 0.42 (0.15–1.17) |
200–349 | 0.88 (0.36–2.19) | 0.31 (0.09–1.06) | 0.84 (0.33–2.15) | 0.20* (0.05–0.75) |
≥350 | 1.20 (0.41–3.48) | 0.39 (0.08–1.91) | 0.84 (0.26–2.68) | 0.14* (0.03–0.77) |
ART status | ||||
HIV-positive on ART | Ref. | Ref. | Ref. | Ref. |
HIV- positive not on ART | 2.26** (1.23–4.14) | 4.53*** (2.03–10.10) | 2.27* (1.15–4.47) | 7.38*** (2.95–18.47) |